Real-world data on utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer: impact on surgical complications and oncological efficacy

Real-world data on utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer: impact on surgical complications and oncological efficacy

Background and purpose: Recommended treatment of urothelial muscle-invasive bladder cancer (MIBC) is cisplatin-based neoadjuvant chemotherapy (NAC) followed by cystectomy, but there are challenges with low utilization of NAC. We aimed to evaluate the utilization of NAC, perioperative complications a...

Full description

Saved in:
Bibliographic Details
Main Authors: Hege S. Haugnes, Hakon Kjaeve, Eivind Bjerkaas, Ragnhild Hellesnes, Line Hjelle, Magnus Larsen
Format: Article
Language:English
Published: Medical Journals Sweden 2025-01-01
Series:Acta Oncologica
Subjects:
neoadjuvant chemotherapy
cisplatin
cystectomy
bladder cancer
muscle-invasive
utilization
Online Access:https://medicaljournalssweden.se/actaoncologica/article/view/42052
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items